美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NewLink Genetics Corp.

0.8900

+0.0000

成交量：- -

成交额：- -

市值：3,319.70万

市盈率：-0.77

高：0.8900

开：0.8900

低：0.8900

收：0.8900

数据加载中...

总览公司新闻公告

公司资料

公司名字：

NewLink Genetics Corp.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.newlinkgenetics.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Newlink Genetics Corporation是一家生物制药公司，专注于发现、开发和商业化免疫治疗产品，改善癌症患者的治疗方案。公司的产品包括生物和小分子免疫治疗候产品。公司的生物产品是基于公司的专有超急性免疫治疗技术，其目的是刺激人体免疫系统。公司的小分子产品的重点是通过抑制吲哚胺-(2、3)-加双氧酶途径打破癌症免疫系统的容忍度。公司相信公司免疫治疗技术有可能产生多个产品针对广泛的肿瘤症状治疗，其可以单独或结合其他疗法进行治疗。该公司于1999年6月4日以NewLink Genetics Corporation为名在特拉华州成立。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NLNK/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NLNK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","market":"US","secType":"STK","nameCN":"NewLink Genetics Corp.","latestPrice":0.89,"timestamp":1584561600000,"preClose":0.89,"halted":8,"volume":0,"delay":0,"floatShares":22854328,"shares":37300000,"eps":-1.15,"marketStatus":"盘后交易","change":0,"latestTime":"05-06 18:11:41 EDT","open":0.89,"high":0.89,"low":0.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.15,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746576000000},"marketStatusCode":4,"symbolChange":{"newSymbol":"LUMO","executeDate":"2020-03-19"},"adr":0,"adrRate":0,"listingDate":1320987600000,"exchange":"NASDAQ","adjPreClose":0.89,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NLNK\",,,,,undefined,":{"symbol":"NLNK","floatShares":22854328,"roa":"-21.70%","roe":"-44.31%","lyrEps":-1.152689,"shares":37300000,"dividePrice":0,"high":0.89,"amplitude":0,"preClose":0.89,"low":0.89,"week52Low":0.8403,"pbRate":"0.42","week52High":3.6,"institutionHeld":0,"latestPrice":0.89,"eps":-1.15,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.15,"open":0.89},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.newlinkgenetics.com","stockEarnings":[{"period":"1week","weight":-0.8889},{"period":"1month","weight":-0.8889},{"period":"3month","weight":-0.8889},{"period":"6month","weight":-0.8889},{"period":"1year","weight":-0.8889},{"period":"ytd","weight":-0.8889}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Newlink Genetics Corporation是一家生物制药公司，专注于发现、开发和商业化免疫治疗产品，改善癌症患者的治疗方案。公司的产品包括生物和小分子免疫治疗候产品。公司的生物产品是基于公司的专有超急性免疫治疗技术，其目的是刺激人体免疫系统。公司的小分子产品的重点是通过抑制吲哚胺-(2、3)-加双氧酶途径打破癌症免疫系统的容忍度。公司相信公司免疫治疗技术有可能产生多个产品针对广泛的肿瘤症状治疗，其可以单独或结合其他疗法进行治疗。该公司于1999年6月4日以NewLink Genetics Corporation为名在特拉华州成立。","exchange":"NASDAQ","name":"NewLink Genetics Corp.","nameEN":"NewLink Genetics Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NLNK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-03-19","symbol":"NLNK","oldSymbol":"NLNK","newSymbol":"LUMO","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584590400000},{"market":"US","date":"2020-03-19","symbol":"NLNK","type":"split","dateTimestamp":1584590400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2020-02-28","symbol":"NLNK","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盘前","type":"earning","dateTimestamp":1582866000000,"reportTimeType":"pre","actualEps":-1.98},{"date":"2019-11-06","symbol":"NLNK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.27,"defaultRemindTime":1573030800000,"name":null,"time":"盘前","dateTimestamp":1573016400000,"actualEps":null},{"market":"US","date":"2019-05-08","symbol":"NLNK","fiscalQuarterEnding":"2019/03","expectedEps":-0.31,"name":null,"time":"盘后","type":"earning","dateTimestamp":1557288000000,"reportTimeType":"post","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NLNK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NLNK\",market:\"US\",delay:false,,,undefined,":{}}}